DarioHealth Corp. (DRIO)
NASDAQ: DRIO · Real-Time Price · USD
7.18
-0.18 (-2.45%)
Aug 18, 2026, 4:00 PM EDT - Market closed
DarioHealth Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, DarioHealth stock has a consensus rating of "Buy" and an average price target of $14.5. The average 1-year stock price forecast is 101.95% higher than the current stock price, while the lowest is $8.00 (+11.42%) and the highest is $28 (+289.97%).
Price Target: $14.5 (+101.95%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for DarioHealth stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Mar '26 | Apr '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Hold Reiterates $11 → $8 | Hold | Reiterates | $11 → $8 | +11.42% | Aug 12, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Maintains $10 | Buy | Maintains | $10 | +39.28% | May 15, 2026 |
Financial Forecast
Revenue This Year
21.66M
from 22.36M
Decreased by -3.14%
Revenue Next Year
31.82M
from 21.66M
Increased by 46.92%
EPS This Year
-2.47
from -7.33
EPS Next Year
-1.12
from -2.47
EPS and Forward PE are based on non-GAAP adjusted numbers.